Charles Taylor announces Edward Creasy as upcoming Chairman of its Board of Directors

– UK, London – The Board of Charles Taylor today announces that Edward Creasy will be appointed Chairman in succession to Rupert Robson, following the release of the Company’s half year results on 28 August 2015.

Edward Creasy was appointed as an independent Non-executive Director of Charles Taylor on 1 January 2014. He has had a long career in the London Market Insurance industry and was formerly chairman of the Kiln Group. He currently holds a number of other senior non-executive directorships. He is a Member of the Council of Lloyd’s Market Supervision and Review Committee and was previously a Director of the Lloyd’s Franchise Board.

The appointment follows a thorough search process which was led by Gill Rider, Senior Independent Non-Executive Director, on behalf of the Board.

Gill Rider said: “We agreed unanimously that Edward’s senior level board experience and extensive knowledge of the London insurance market makes him the ideal person to chair Charles Taylor.”

About Charles Taylor plc

Charles Taylor plc is a leading provider of professional services to clients across the global insurance market. The Group has been providing services since 1884 and today employs over 1,200 staff in 69 offices spread across 28 countries in the UK, the Americas, Asia Pacific, Europe, the Middle East and Africa.

The Group offers services, principally on a fee-based model and operates through three businesses – Management, Adjusting and Insurance Support Services. Charles Taylor also owns insurers, creating value through select acquisitions and operational efficiency.

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

here, the original post =>